1-4 of 4
Susan C. Locke, PhD
Close
Sort by
Journal Articles

Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors

Jesse D Troy, PhD MPH, Susan C. Locke, PhD, Mary Ruth Pupa, BSN, Joseph Feliciano, PharmD, Akshara Richhariya, PhD, Thomas W. LeBlanc, MD MA
Journal: Blood
Blood (2017) 130 (Supplement 1): 2173.
https://doi.org/10.1182/blood.V130.Suppl_1.2173.2173
Published: 2017
Journal Articles

Patient Experiences of Acute Myeloid Leukemia (AML): A Qualitative Study about Diagnosis, Illness Understanding, and Treatment Decision-Making

Thomas W. LeBlanc, MD MA, Laura J Fish, PhD, Catherine T Bloom, MPH, Areej El-Jawahri, MD, Debra M Davis, RN, MSEd, Susan C Locke, PhD, Kathryn I Pollak, PhD
Journal: Blood
Blood (2015) 126 (23): 2119.
https://doi.org/10.1182/blood.V126.23.2119.2119
Published: 2015
Journal Articles

Symptom Burden, Quality of Life, and Distress in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy: Results of a Prospective Electronic Patient-Reported Outcomes Study

Thomas W. LeBlanc, MD MA, Steven P Wolf, MS, Areej El-Jawahri, MD, Debra M Davis, RN, MSEd, Susan C Locke, PhD, Amy Abernethy, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4496.
https://doi.org/10.1182/blood.V126.23.4496.4496
Published: 2015
Journal Articles

Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices

Thomas W. LeBlanc, MD MA, Catherine T Bloom, Debra M Davis, RN, Susan C Locke, PhD, Karen E Steinhauser, PhD, Peter A Ubel, MD, James A Tulsky, MD, Amy P Abernethy, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1280.
https://doi.org/10.1182/blood.V124.21.1280.1280
Published: 2014